Canonical Chinese medicine formula Danzhi-Xiaoyao-San for treating depression: A systematic review and meta-analysis

荟萃分析 随机对照试验 医学 萧条(经济学) 内科学 系统回顾 中医药 汉密尔顿抑郁量表 传统医学 梅德林 替代医学 重性抑郁障碍 病理 生物 经济 生物化学 宏观经济学 扁桃形结构
作者
Xiaole Wang,Sitong Feng,Yating Wang,Ningning Zhang,Zhen‐Zhen Wang,Yi Zhang
出处
期刊:Journal of Ethnopharmacology [Elsevier BV]
卷期号:287: 114960-114960 被引量:24
标识
DOI:10.1016/j.jep.2021.114960
摘要

Danzhi-Xiaoyao-San (DXS), as a canonical Chinese medicine formula, possessing the functions of the soothing liver, invigorating spleen, clearing heat, and cooling blood, has been widely used for the treatment of depression.This systematic review and meta-analysis of randomized controlled trials aimed to examine the efficacy of DXS in depression.We performed a literature search in several databases, e.g., PUBMED, until August 2021 and conducted the meta-analysis using Review Manager 5.3 software. The random-effects model and fixed-effects model were used to synthetize extracted data.Finally, this meta-analysis showed that comparing with antidepressants, DXS exhibited similar effect to antidepressants in the clinical comprehensive effect [RR = 1.04, 95% CI (0.77, 1.40); P = 0.81] and decrease in Self-Rating Depression Scale scores [WMD = 0.89, 95% CI (-6.33, 8.11); P = 0.81], while lower effect in Hamilton Depression Scale scores [SMD = -0.29, 95% CI (-0.55, -0.03); P = 0.03]; Furthermore, DXS plus antidepressants can significantly improve the clinical comprehensive effect [RR = 1.23, 95% CI (1.17, 1.29); P < 0.00001] and decrease the Hamilton Depression Scale scores [SMD = 1.04, 95% CI (0.51, 1.58); P = 0.0001] than pure antidepressants.This systematic review and meta-analysis approved an efficient role of DXS in improving depression in clinical randomized controlled trials. However, further evidence from large samples and high-quality randomized controlled trials is needed to be investigated for a reliable conclusion about DXS in the treatment of depression.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yyyy发布了新的文献求助10
6秒前
陈1992完成签到 ,获得积分10
8秒前
HEIKU应助罗Eason采纳,获得10
9秒前
9秒前
guojinyu应助科研通管家采纳,获得10
11秒前
在水一方应助科研通管家采纳,获得10
12秒前
在水一方应助科研通管家采纳,获得10
12秒前
Puffmomozxy应助科研通管家采纳,获得10
12秒前
在水一方应助科研通管家采纳,获得10
12秒前
12秒前
英姑应助科研通管家采纳,获得10
12秒前
无花果应助科研通管家采纳,获得10
12秒前
8R60d8应助科研通管家采纳,获得10
12秒前
未夕晴发布了新的文献求助10
12秒前
yyyy完成签到,获得积分10
15秒前
义气聪展完成签到 ,获得积分10
17秒前
17秒前
江月完成签到,获得积分10
18秒前
潇洒的擎苍完成签到,获得积分10
19秒前
科研通AI5应助chenmeimei2012采纳,获得10
21秒前
搜集达人应助宏hong采纳,获得10
24秒前
25秒前
28秒前
日富一日完成签到,获得积分20
30秒前
jiaqitang发布了新的文献求助30
31秒前
32秒前
松山少林学武功完成签到 ,获得积分10
35秒前
JY发布了新的文献求助30
36秒前
tpt发布了新的文献求助10
36秒前
36秒前
Camille完成签到,获得积分10
37秒前
斯寜应助大胆的弼采纳,获得10
37秒前
小肖的KYT完成签到,获得积分10
38秒前
可爱的函函应助日富一日采纳,获得10
38秒前
becl完成签到,获得积分10
40秒前
只A不B应助孙国昊采纳,获得20
41秒前
煜琪完成签到 ,获得积分10
41秒前
MOMO完成签到,获得积分10
42秒前
Artemis完成签到,获得积分10
43秒前
45秒前
高分求助中
All the Birds of the World 3000
Weirder than Sci-fi: Speculative Practice in Art and Finance 960
Resilience of a Nation: A History of the Military in Rwanda 500
IZELTABART TAPATANSINE 500
Introduction to Comparative Public Administration: Administrative Systems and Reforms in Europe: Second Edition 2nd Edition 300
Spontaneous closure of a dural arteriovenous malformation 300
Not Equal : Towards an International Law of Finance 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3726502
求助须知:如何正确求助?哪些是违规求助? 3271513
关于积分的说明 9972496
捐赠科研通 2986962
什么是DOI,文献DOI怎么找? 1638552
邀请新用户注册赠送积分活动 778169
科研通“疑难数据库(出版商)”最低求助积分说明 747506